版本:
中国

BRIEF-MaRS Innovation announces acquisition of first compound from Triphase by Celgene

Nov 21 MaRS Innovation:

* Triphase accelerator to sell assets relating to Marizomib to Celgene, via affiliate, for undisclosed amount

* MaRS Innovation announces acquisition of first compound from portfolio company triphase by Celgene Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐